Institutions / Soleus Capital Management, L.P. / Holdings
Back to Soleus Capital Management, L.P.

Soleus Capital Management, L.P.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
Krystal Biotech, Inc.—$232.01M941,0599.8%
Celcuity Inc.CELCCommon Stock$180.36M1,808,2587.7%
NovoCure Ltd—$110.30M8,530,6654.7%
Praxis Precision Medicines, Inc.—$106.98M362,9664.5%
TG Therapeutics Inc—$93.58M3,139,3124.0%
Dexcom Inc—$86.09M1,297,0943.7%
BioMarin Pharmaceutical Inc—$78.45M1,320,0003.3%
Globus Medical Inc—$77.44M887,0003.3%
Beta Bionics, Inc.—$77.23M2,534,5653.3%
AMICUS THERAPEUTICS INC—$74.15M5,207,2843.1%
Twist Bioscience Corp—$59.06M1,861,8022.5%
ORGANOGENESIS HOLDINGS INC.ORGOCommon Stock$51.73M9,985,9512.2%
Syndax Pharmaceuticals Inc—$47.21M2,247,1102.0%
Mirum Pharmaceuticals, Inc.—$45.31M573,6141.9%
Insulet Corp—$42.64M150,0001.8%
NeuroPace Inc—$41.74M2,703,2081.8%
Axogen, Inc.—$39.50M1,206,8551.7%
ANI PHARMACEUTICALS INC—$38.38M486,2431.6%
Alkermes plc.—$37.00M1,322,3641.6%
LivaNova PLC—$34.92M567,5001.5%
GSK PLC—$31.34M639,0001.3%
GERON CORP—$30.74M23,290,0001.3%
United Therapeutics Corp—$29.23M60,0001.2%
Immunovant, Inc.IMVTCommon Stock$28.22M1,110,0001.2%
VAXCYTE, INC.—$28.10M608,9581.2%
Alnylam Pharmaceuticals Inc—$27.84M70,0001.2%
Inspire Medical Systems, Inc.—$27.61M299,3991.2%
Vericel Corp—$27.51M764,0001.2%
ARGENX SE—$26.68M31,7261.1%
RAPT THERAPEUTICS INC—$25.88M764,0001.1%
NEUROCRINE BIOSCIENCES INC—$24.96M175,9821.1%
Kiniksa Pharmaceuticals International, plc—$24.21M587,0001.0%
EDAP TMS S A—$24.05M7,309,2541.0%
TELEFLEX INC—$23.19M190,0001.0%
Nurix Therapeutics, Inc.—$23.13M1,219,3941.0%
Edgewise Therapeutics, Inc.—$22.58M910,0001.0%
Inhibikase Therapeutics, Inc.—$22.29M10,875,0000.9%
Pharvaris N.V.—$19.48M702,0520.8%
Invivyd, Inc.—$19.04M7,708,7270.8%
CAPRICOR THERAPEUTICS, INC.—$18.65M646,3900.8%
TENET HEALTHCARE CORP—$18.38M92,5000.8%
Arcus Biosciences, Inc.—$16.97M711,9830.7%
Enliven Therapeutics, Inc.ELVNCommon Stock$15.79M1,025,0000.7%
MBX Biosciences, Inc.MBXCommon Stock$12.90M408,9000.5%
RIGEL PHARMACEUTICALS, INC.—$12.85M300,0340.5%
JADE BIOSCIENCES, INC.—$12.29M796,7440.5%
Trevi Therapeutics, Inc.—$11.27M900,0000.5%
Sionna Therapeutics, Inc.—$11.05M268,5000.5%
Septerna, Inc.SEPNCommon Stock$10.69M383,3680.5%
ORTHOPEDIATRICS CORPKIDSCommon Stock$9.33M525,4470.4%
← PrevPage 1 of 2Next →